Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
Titel:
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
Auteur:
Selmaj, Krzysztof Li, David KB Hartung, Hans-Peter Hemmer, Bernhard Kappos, Ludwig Freedman, Mark S Stüve, Olaf Rieckmann, Peter Montalban, Xavier Ziemssen, Tjalf Auberson, Lixin Zhang Pohlmann, Harald Mercier, Francois Dahlke, Frank Wallström, Erik